Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
Die Pharmazie
|
January 2, 2014
Pharmacoeconomic analysis of DPP-4 inhibitors
H Teramachi, H Ohta, T Tachi, et al.
The Journal of Hospital Infection
|
May 25, 2017
Economic evaluation of infection control activities
T Seko, T Tachi, N Kawashima, et al.
Biopolymers
|
February 17, 2001
Effects of peptide dimerization on pore formation: Antiparallel disulfide-dimerized magainin 2 analogue
T Hara, H Kodama, M Kondo, et al.
Die Pharmazie
|
May 22, 2019
Association between dipeptidyl peptidase-4 inhibitors and autoimmune disorders: Data mining of the spontaneous reporting system in Japan
Y Noguchi, Y Toda, H Esaki, et al.
Die Pharmazie
|
February 15, 2018
An investigation of visual hallucinations associated with voriconazole administration to patients with hematological malignancies
H Sakurada, K Yasuhara, K Kato, et al.
Die Pharmazie
|
November 6, 2019
Community pharmacy-level factors associated with medical and nursing home facility collaboration in Japan
Y Ino, A Shimauchi, T Tachi, et al.
Die Pharmazie
|
February 15, 2018
A comparative analysis of micafungin and caspofungin for empirical antifungal therapy in antibiotic-unresponsive febrile patients with hematologic malignancies
T Seko, E Usami, M Kimura, et al.
Journal of Clinical Pharmacy and Therapeutics
|
May 16, 2017
A rapid method to screen poisoning causative agents in an acute care hospital in Japan
K Usui, H Mori, T Tachi, et al.
Die Pharmazie
|
February 15, 2018
Evaluation of antimicrobial stewardship (AS) for appropriate use of antimicrobial agents
T Matsuoka, M Kato, Y Shinoda, et al.
Die Pharmazie
|
April 6, 2013
Risk factors contributing to urinary protein expression resulting from bevacizumab combination chemotherapy
H Teramachi, H Shiga, N Komada, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
Die Pharmazie
|
January 2, 2014
Pharmacoeconomic analysis of DPP-4 inhibitors
H Teramachi, H Ohta, T Tachi, et al.
The Journal of Hospital Infection
|
May 25, 2017
Economic evaluation of infection control activities
T Seko, T Tachi, N Kawashima, et al.
Biopolymers
|
February 17, 2001
Effects of peptide dimerization on pore formation: Antiparallel disulfide-dimerized magainin 2 analogue
T Hara, H Kodama, M Kondo, et al.
Die Pharmazie
|
May 22, 2019
Association between dipeptidyl peptidase-4 inhibitors and autoimmune disorders: Data mining of the spontaneous reporting system in Japan
Y Noguchi, Y Toda, H Esaki, et al.
Die Pharmazie
|
February 15, 2018
An investigation of visual hallucinations associated with voriconazole administration to patients with hematological malignancies
H Sakurada, K Yasuhara, K Kato, et al.
Die Pharmazie
|
November 6, 2019
Community pharmacy-level factors associated with medical and nursing home facility collaboration in Japan
Y Ino, A Shimauchi, T Tachi, et al.
Die Pharmazie
|
February 15, 2018
A comparative analysis of micafungin and caspofungin for empirical antifungal therapy in antibiotic-unresponsive febrile patients with hematologic malignancies
T Seko, E Usami, M Kimura, et al.
Journal of Clinical Pharmacy and Therapeutics
|
May 16, 2017
A rapid method to screen poisoning causative agents in an acute care hospital in Japan
K Usui, H Mori, T Tachi, et al.
Die Pharmazie
|
February 15, 2018
Evaluation of antimicrobial stewardship (AS) for appropriate use of antimicrobial agents
T Matsuoka, M Kato, Y Shinoda, et al.
Die Pharmazie
|
April 6, 2013
Risk factors contributing to urinary protein expression resulting from bevacizumab combination chemotherapy
H Teramachi, H Shiga, N Komada, et al.
Page
of 4